Certiorari Granted For A Second Time In Cancer Gene Patent Dispute

WASHINGTON, D.C. - (Mealey's) Less than a year after it returned to the Federal Circuit U.S. Court of Appeals a patent lawsuit over diagnostic test kits for determining hereditary risk of breast and ovarian cancer, the U.S. Supreme Court on Nov. 30 announced it will again take up the case ( The Association...